克罗地亚成人特应性皮炎患者FLG功能丧失突变及FLG降解产物水平研究
本研究纳入100例中重度成人特应性皮炎(AD)患者和50例健康对照,筛查三种FLG功能丧失突变(R501X、2282del4、R2447X),并检测角质层NMF、TEWL和pH。AD组突变频率为4%且均为纯合携带者,对照组无突变;病变皮肤NMF显著降低,但非病变皮肤与对照无显著差异。研究提示FLG缺陷在克罗地亚人群中并非AD的主要风险因素。
要点
- 克罗地亚成人AD患者FLG突变频率低(4%),且均为纯合携带者。
- AD患者病变皮肤NMF显著降低,但非病变皮肤与健康对照无显著差异。
- AD患者病变和非病变皮肤的TEWL和pH均升高。
核心结论
- 克罗地亚成人AD患者中FLG功能丧失突变频率低,且非病变皮肤FLG降解产物水平与健康对照相似,提示FLG缺陷并非该人群AD的主要风险因素。
研究设计与样本
- 研究纳入100例中重度成人AD患者和50例健康对照,筛查三种FLG突变(R501X、2282del4、R2447X),并用胶带采集角质层样本检测NMF,同时测定病变和非病变皮肤的TEWL和pH。
主要发现
- AD组FLG突变合并频率为4%,均为纯合携带者;对照组未发现突变。
- AD患者中最常见的FLG突变为2282del4(3%),其次为R501X(1%)。
- 与健康对照相比,AD患者病变皮肤NMF值强烈降低,但非病变皮肤无显著差异。
- AD患者病变和非病变皮肤的TEWL均升高,pH也呈现相同模式。
临床怎么用
- 在克罗地亚AD患者中,FLG突变筛查可能不是常规必要项目,因突变频率低且非病变皮肤FLG降解产物水平正常。
局限性
- 研究仅筛查三种FLG突变,可能遗漏其他罕见突变;样本量有限,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: FLG loss-of-function mutations (FLG LOF) represent the strongest genetic risk factor for atopic dermatitis (AD) and are associated with early-onset and more severe disease. The prevalence of FLG mutations varies greatly across Europe. At present, there are no data on FLG mutation prevalence in Croatian AD patients. OBJECTIVES: To investigate the prevalence of FLG LOF mutations in adult patients with AD and healthy controls. Next to measure the stratum corneum (SC) levels of filaggrin degradation products (NMF), transepidermal water loss (TEWL) and pH in lesional and non-lesional skin. METHODS: We recruited 100 AD patients with moderate to severe disease and 50 healthy controls. They were screened for three FLG mutations (R501X, 2282del4 and R2447X). Samples of the SC for NMF analysis were collected by adhesive tapes. TEWL and skin surface pH levels were determined on the lesional and non-lesional skin. RESULTS: The combined mutation frequency was 4% in the AD group, and all patients with FLG mutations were homozygous carriers. In the control group, no mutations were found. The most common FLG mutation in AD patients was 2282del4 (3%), followed by R501X (1%). As compared to healthy controls, NMF values were strongly reduced in lesional skin; however, no significant difference was found for non-lesional skin. AD patients had elevated TEWL in both lesional and non-lesional skin. The same pattern was observed for pH. CONCLUSIONS: Our study expands understanding of the landscape of FLG mutations in the European population. The low frequency of FLG mutations and similar levels of filaggrin degradation products in healthy controls and in non-lesional skin of AD patients suggest that filaggrin deficiency does not confer a major risk for AD in the Croatian population.
引用
- Jurakic Toncic R, Kezic S, Jakasa I, et al. Filaggrin loss-of-function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia. J Eur Acad Dermatol Venereol. 2020. PMID: 31989686. doi:10.1111/jdv.16232
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。